Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2025
Development and validation of a diagnostic model for symptomatic large artery atherosclerotic stenosis: integrating lipid metabolism, coagulation, and inflammatory biomarkers.
СтатьяВалидационное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chen Yajie, Xue Qun, Huang Tingting, Xiong Yuwei, Zhao Shoucai, Xu Yang
Аннотация
BACKGROUND: Early diagnosis of symptomatic large artery atherosclerotic stenosis (sLAAS) is crucial for therapeutic decision-making. Reliance on imaging for sLAAS diagnosis generates substantial obstacles in resource-constrained settings. This challenge prompted the development of an accessible diagnostic model using routinely available clinical parameters, enabling sLAAS diagnosis when advanced imaging is unavailable.
METHODS: This study included acute ischemic stroke (AIS) patients with imaging-confirmed large artery atherosclerotic stenosis (LAAS). Biomarkers of sLAAS initially filtered by least absolute shrinkage and selection operator (LASSO) regression were further assessed using multivariable logistic regression. We subsequently developed a clinically applicable diagnostic tool based on a nomogram, and validated the model's performance in a separate cohort.
RESULTS: A total of 318 AIS patients with LAAS were included in this study. Multivariable logistic regression confirmed lipoprotein-associated phospholipase A2 (Lp-PLA2), triacylglycerol (TG), fibrinogen (FIB), and aggregate index of systemic inflammation (AISI) as independent biomarkers of sLAAS. The nomogram exhibited strong diagnostic performance, with the area under the receiver operating characteristic curve (AUC-ROC) of 0.860 in the training set and 0.837 in the validation set. Both calibration curves and decision curve analysis (DCA) validated the robust performance of the model.
CONCLUSIONS: We developed a diagnostic model for sLAAS that integrates lipid metabolism, coagulation, and inflammatory biomarkers. This model enables accurate sLAAS identification, demonstrating specific value in resource-constrained settings.
METHODS: This study included acute ischemic stroke (AIS) patients with imaging-confirmed large artery atherosclerotic stenosis (LAAS). Biomarkers of sLAAS initially filtered by least absolute shrinkage and selection operator (LASSO) regression were further assessed using multivariable logistic regression. We subsequently developed a clinically applicable diagnostic tool based on a nomogram, and validated the model's performance in a separate cohort.
RESULTS: A total of 318 AIS patients with LAAS were included in this study. Multivariable logistic regression confirmed lipoprotein-associated phospholipase A2 (Lp-PLA2), triacylglycerol (TG), fibrinogen (FIB), and aggregate index of systemic inflammation (AISI) as independent biomarkers of sLAAS. The nomogram exhibited strong diagnostic performance, with the area under the receiver operating characteristic curve (AUC-ROC) of 0.860 in the training set and 0.837 in the validation set. Both calibration curves and decision curve analysis (DCA) validated the robust performance of the model.
CONCLUSIONS: We developed a diagnostic model for sLAAS that integrates lipid metabolism, coagulation, and inflammatory biomarkers. This model enables accurate sLAAS identification, demonstrating specific value in resource-constrained settings.